medline.ch Dermatologie Tumoren Melanom

	Melanoma treatment in the era of nanotechnology and precision medicine. J Nanobiotechnology da Cruz AF, Colella F, Grasso G, Onesto V, Forciniti S, Ortiz BB, Carnevali F, Siciliano AC, Bove R, Gonçalves Dos Santos J, Iuele H, Zub EC, Gigli G, Del Mercato LL, Camargo de Oliveira C. PMID: 41419864 [PubMed - as supplied by publisher]
	Prospective standardized surveillance of early-stage melanoma on the basis of anatomical staging and molecular profiling: Study design and interim analysis. Surgery Aubrey JM, Kelley J, Khan M, Kolbeinsson H, Liefeld H, Preihs R, Bengel A, Koch C, Martin L, Charchan J, Texley-Quigg K, Melnik M, Wright GP. PMID: 41419392 [PubMed - as supplied by publisher]
	Enhancing Diagnostic Precision in Primary Care: A Multireader Multicase (MRMC) Study of an AI-Powered Handheld Elastic Scattering Spectroscopy Device for Informed Referral Decisions in Melanoma Evaluation. J Clin Aesthet Dermatol Seiverling EV, Shah A, Weinstock MA, Grant-Kels JM, Falk NP, Siegel DM. PMID: 41416030 [PubMed]
	Competing risk analysis of prognosis in patients with uveal melanoma. Discov Oncol Huang R, Chen J, Lyu J, Zhou Q, Lin L. PMID: 41413733 [PubMed - as supplied by publisher]
	Independent Dutch Validation Study of CP-GEP (Merlin Assay) for the Prediction of Nodal Metastasis and Long-Term Outcome in Patients with Primary Cutaneous Melanoma. Ann Surg Oncol Zijlker LP, Verwer Z, van der Wiel BA, Kuijpers AMJ, Wouters MWJM, van Houdt WJ, van Akkooi ACJ. PMID: 41413281 [PubMed - as supplied by publisher]
	P22 Using VECTRA and AI analysis to monitor paediatric lesions: a review of cases. Br J Dermatol Baird J, Murrell D. PMID: 41412984 [PubMed - indexed for MEDLINE]
	Exploring the Impact of Foods and Dietary Patterns on Melanoma Risk. Cureus Kalavsky M, Abdul Gafoor SM. PMID: 41409372 [PubMed]
	A Case Report of a Comparative Approach in a Patient with Multiple Seborrheic Keratosis: Does It Work for SK-Like Melanoma Screening? Case Rep Dermatol Billah LM, Chiheb S, Mohamed O, Kelati A. PMID: 41409133 [PubMed]
	High BRAF variant allele frequency predicts poor outcomes in metastatic melanoma patients treated with BRAF/MEK inhibitors. J Transl Med Guida M, Apollonio B, Romano L, Spagnolo F, Quaglino P, Depenni R, Pinto R, Squicciarini T, Fucci L, Di Tullio P, Scaini MC, Maccallini MT, Indini A, Troiani T, Natalicchio I, Brugnara S, Lombardo M, Pellegrini C, Queirolo P, Perrone F, Minisini A, Tucci M, Conca R, Costabile S, Macrì M, Tanda E, Croce E, Senetta R, Fava P, Pugliese G, Pellegrini S, Melucci E, Vecchio MD, Caraglia F, Girlando S, De Summa S, Strippoli S, Italian Melanoma Intergroup (IMI). PMID: 41408295 [PubMed - indexed for MEDLINE]
	Dual checkpoint inhibitor therapy versus dual targeted therapy of untreated metastatic BRAF-mutant melanoma: a systematic review of randomised controlled trials. BMJ Open Peinemann F, Baradaran S, Arnolds KB, Hoemberg M. PMID: 41407417 [PubMed - indexed for MEDLINE]
	Evaluating missing outcome data methods for the analysis of the MEL-SELF trial of patient-led surveillance for early-stage melanoma: A simulation study. Contemp Clin Trials Medcalf E, Turner RM, Espinoza D, Zhu L, Bell KJL. PMID: 41407102 [PubMed - as supplied by publisher]
	3D Total Body Photography as a Promising Innovation for Early Skin Cancer Detection: Scoping Review. JMIR Dermatol Baete F, Jakers AL, Delanoye E, Vande Velde N, Voet G. PMID: 41406351 [PubMed - indexed for MEDLINE]
	Nail Matrix Melanoma in Adolescents and Young Adults-A Retrospective Dermoscopic Study. Clin Exp Dermatol Akay BN, Ongun F, Heper AO, Ayça K, Alpat SE, Kocyigit P. PMID: 41403034 [PubMed - as supplied by publisher]
	Comparative cost analysis of a diagnostic multi-omics platform for decision support in advanced cancer - results from the Tumor Profiler Melanoma project. NPJ Precis Oncol Mehra T, Menges D, Gosztonyi B, Miglino N, Ring A, Boos L, Sobottka B, Tumor Profiler Consortium, Koelzer VH, Moch H, Toussaint NC, Levesque M, Ramelyte E, Mangana J, Dummer R, Wicki A. PMID: 41402424 [PubMed - as supplied by publisher]
	Correction to "Intratumoral vidutolimod as monotherapy or in combination with pembrolizumab in patients with programmed cell death 1 blockade-resistant melanoma: Final analysis from a phase 1b study". Cancer PMID: 41400338 [PubMed - in process]
	Unravelling the crosstalk: Anti-fibrotic agents and MAPK inhibitors in the treatment of melanoma. Crit Rev Oncol Hematol Swathika R, Nayak Y, Prasad As B, Nayak UY. PMID: 41397586 [PubMed - as supplied by publisher]
	Cost-effective Mueller matrix microscopy for label-free differentiation of melanoma from normal skin and common skin cancer types. Biomed Opt Express Du Le VN, Bolden A. PMID: 41394488 [PubMed]
	Preoperative primary tumor SUVmax on PET/CT correlates with Breslow thickness and is associated with survival in melanoma: A retrospective cohort study. JAAD Int Chang YH, Huang YH, Pan SC, Yu-Yun Lee J, Wu CL, Wong TW, Lu HH, Liu WT. PMID: 41393353 [PubMed]
	Toward Precision Medicine: Gene Therapy Applications in the Management of Uveal Melanoma. Cancer Rep (Hoboken) Azani A, Ghassemifar V, Mehrdad Z, Saberivand M, Bagheripour A, Tahmasebi S, Gharedaghi H, Sharafi M, Foroozand H, Soleimani Meigoli MS, Pourali S, Salmaninejad A, Ahmadi Beni F, Behfar Q. PMID: 41392397 [PubMed - indexed for MEDLINE]
	Five-year clinical outcome and immune biomarkers of durable response from the MM1636 trial on IDO/PD-L1 vaccination and PD-1 blockade in first line metastatic melanoma. Nat Commun Pedersen S, Byrdal M, Martinenaite E, Lorentzen CL, Kjeldsen JW, Thorsen SU, Kverneland A, Zocca MB, Andersen MH, Svane IM. PMID: 41392152 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 44695

Seite 1 von 2235

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung